Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosis

1 Jan 2022

Abstract excerpt

Background: MicroRNAs are short nucleotide sequences that contribute to the regulation of various biological functions and therefore their roles have been investigated in many pathologic conditions such as epithelial to mesenchymal transition in cancer and fibrosis; among them, miR-138 has been mostly studied in cancer biology and is well-known for its suppressing effect on cancer progression. Being able to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Extracellular vesicles in disease
Share to MicroRNA in disease regulation
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36518749
DOI: 10.1177/11772719221135442

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosisPMID 36518749Read ↗

Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosisSemantic proximity Read ↗

microRNA-92a expression in the sera and dermal fibroblasts increases in patients with sclerodermaSemantic proximity Read ↗

MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in sclerodermaSemantic proximity Read ↗

MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosisSemantic proximity Read ↗

The Circulating Cell-free microRNA Profile in Systemic Sclerosis Is Distinct from Both Healthy Controls and Systemic Lupus ErythematosusSemantic proximity Read ↗

Circulating miRNA-181b-5p, miRNA-223-3p, miRNA-210-3p, let 7i-5p, miRNA-21-5p and miRNA-29a-3p in patients with localized scleroderma as potential biomarkersSemantic proximity Read ↗

MicroRNA-29: a potential therapeutic target for systemic sclerosisSemantic proximity Read ↗

Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis.Semantic proximity Read ↗

Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene SignaturesSemantic proximity Read ↗

microRNA27a-3p mediates reduction of the Wnt antagonist sFRP-1 in systemic sclerosisSemantic proximity Read ↗

Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor βSemantic proximity Read ↗

TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.